- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scribe Therapeutics Inc (SCTX)
Scribe Therapeutics Inc stock price live, this page displays NASDAQ SCTX stock exchange data. View the SCTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Scribe Therapeutics Inc real time stock price chart below.
What Is the Scribe Therapeutics Inc Stock Price Today?
The Scribe Therapeutics Inc stock price today is 21.61.
What Is the Stock Symbol for Scribe Therapeutics Inc?
The stock symbol for Scribe Therapeutics Inc is "SCTX."
What Stock Exchange Does Scribe Therapeutics Inc Trade On?
Scribe Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Scribe Therapeutics Inc a Good Stock to Buy?
Determining whether Scribe Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCTX quote. (ISIN: US8110331092)
What Is the Scribe Therapeutics Inc Stock Price Today?
The Scribe Therapeutics Inc stock price today is 21.61.
What Is the Stock Symbol for Scribe Therapeutics Inc?
The stock symbol for Scribe Therapeutics Inc is "SCTX."
What Stock Exchange Does Scribe Therapeutics Inc Trade On?
Scribe Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Scribe Therapeutics Inc a Good Stock to Buy?
Determining whether Scribe Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCTX quote. (ISIN: US8110331092)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.36
26.27
52 wk Range
15.00
39.60
SCTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.3626.27
52 wk Range
15.0039.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SCTX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
57.00
Upside
+163.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 57.00
(+163.77% Upside)
Earnings
Latest Release
Sep 02, 2026
EPS / Forecast
-2.62 / --
Revenue / Forecast
1.9M / --
Compare SCTX to Peers and Sector
Metrics to compare | SCTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.5x | −16.3x | −0.4x | |
PEG Ratio | - | −0.31 | 0.00 | |
Price/Book | −3.0x | 10.2x | 2.6x | |
Price / LTM Sales | 15.1x | 34.1x | 3.1x | |
Upside (Analyst Target) | 114.9% | 59.2% | 55.6% | |
Fair Value Upside | Unlock | −20.4% | 7.8% | Unlock |
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Scribe Therapeutics (SCTX) Stock Price Today?
The Scribe Therapeutics stock price today is 21.61 USD.
What Stock Exchange Does Scribe Therapeutics Trade On?
Scribe Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Scribe Therapeutics?
The stock symbol for Scribe Therapeutics is "SCTX."
What Is the Scribe Therapeutics Market Cap?
As of today, Scribe Therapeutics market cap is 502.26M USD.
What Is Scribe Therapeutics's Earnings Per Share (TTM)?
The Scribe Therapeutics EPS (TTM) is -13.18.
When Is the Next Scribe Therapeutics Earnings Date?
Scribe Therapeutics will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is SCTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Scribe Therapeutics Stock Split?
Scribe Therapeutics has split 0 times.
How Many Employees Does Scribe Therapeutics Have?
Scribe Therapeutics has 82 employees.
What is the current trading status of Scribe Therapeutics (SCTX)?
As of Sep 24, 2026, Scribe Therapeutics (SCTX) is trading at a price of 21.61 USD, with a previous close of 26.53 USD. The stock has fluctuated within a day range of 21.36 USD to 26.27 USD, while its 52-week range spans from 15.00 USD to 39.60 USD.
What Is Scribe Therapeutics (SCTX) Price Target According to Analysts?
The average 12-month price target for Scribe Therapeutics is 57.00 USD, with a high estimate of 60 USD and a low estimate of 50 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +163.77% Upside potential.
What Is the SCTX Premarket Price?
SCTX's last pre-market stock price is 26.50 USD. The pre-market share volume is 4,320.00, and the stock has decreased by -0.03, or -0.11%.
What Is the SCTX After Hours Price?
SCTX's last after hours stock price is 21.62 USD, the stock has decreased by 0.01, or 0.05%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.